Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 486 (RNA5SP486) is a processed pseudogene of the 5S ribosomal RNA gene family. Like other rRNA pseudogenes, it arose via retrotransposition and generally lacks introns and protein-coding potential[2][4]. Unlike functional 5S rRNA—which plays a central structural and communication role in the ribosome’s large subunit, transmitting allosteric signals between functional centers and stabilizing ribosomal assembly[1][3][5]—the RNA5SP486 pseudogene does not encode a functional RNA molecule and is not incorporated into ribosomes. While some pseudogenes can regulate gene expression by RNA-mediated mechanisms (e.g., acting as RNA decoys for RNA-binding proteins), there is no evidence that RNA5SP486 has such a role[2]. It is not regarded as a therapeutic target, biomarker, or safety concern. The inclusion of the term “486” simply denotes its place among annotated pseudogenes of the 5S rRNA family; it does not signify any unique biological or clinical relevance for this specific locus.
None (no known mechanism as target; parental rRNA participates in translation, not drug targets)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 486 (RNA5SP486).